title: Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.
abstract: Hypertrophic cardiomyopathy (HCM), the most variable cardiac disease in terms of phenotypic presentation and clinical outcome, represents the most common inherited cardiomyopathic process with an autosomal dominant trait of inheritance. To date, more than 1400 mutations of myofilament proteins associated with the disease have been identified, most of them "private" ones. This striking allelic and locus heterogeneity of the disease certainly complicates the establishment of phenotype-genotype correlations. Additionally, topics pertaining to patients' everyday lives, such as sudden cardiac death (SCD) risk stratification and prevention, along with disease prognosis, are grossly related to the genetic variation of HCM. This review incorporates contemporary research findings and addresses major aspects of HCM, including preclinical diagnosis, genetic analysis, left ventricular outflow tract obstruction and SCD. More specifically, the spectrum of genetic analysis, the selection of the best method for obstruction alleviation and the need for a unique and accurate factor for SCD risk stratification are only some of the controversial HCM issues discussed. Additionally, future perspectives concerning HCM and myocardial ischemia, as well as atrial fibrillation, are discussed. Rather than enumerating clinical studies and guidelines, challenging problems concerning the disease are critically appraised by this review, highlighting current speculations and recommending future directions.
authors.affiliation: Georgios K Efthimiadis, Efstathios D Pagourelias, Thomas Gossios, Thomas Zegkos, Cardiomyopathies Center, First Cardiology Department, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54622 Thessaloniki, Greece.
authors.forename: Georgios K
authors.initials: GK
authors.lastname: Efthimiadis
authors.affiliation: Georgios K Efthimiadis, Efstathios D Pagourelias, Thomas Gossios, Thomas Zegkos, Cardiomyopathies Center, First Cardiology Department, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54622 Thessaloniki, Greece.
authors.forename: Efstathios D
authors.initials: ED
authors.lastname: Pagourelias
authors.affiliation: Georgios K Efthimiadis, Efstathios D Pagourelias, Thomas Gossios, Thomas Zegkos, Cardiomyopathies Center, First Cardiology Department, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54622 Thessaloniki, Greece.
authors.forename: Thomas
authors.initials: T
authors.lastname: Gossios
authors.affiliation: Georgios K Efthimiadis, Efstathios D Pagourelias, Thomas Gossios, Thomas Zegkos, Cardiomyopathies Center, First Cardiology Department, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54622 Thessaloniki, Greece.
authors.forename: Thomas
authors.initials: T
authors.lastname: Zegkos
keywords: Genetic analysis; Hypertrophic cardiomyopathy; Left ventricular outflow obstruction; Preclinical diagnosis; Sudden cardiac death